News
Form 8.3 - Link Fund Solutions Ltd: Midatech Pharma Plc
Edison Investment Research Limited: Edison issues update on Silence Therapeutics (SLN)
Hardman & Co Research: Diurnal (DNL): $52.5m US deal strengthens balance sheet further
Edison Investment Research Limited: Edison issues update on Silence Therapeutics (SLN)
Edison Investment Research Limited: Edison issues initiation on Ergomed (ERGO)
Hardman & Co Research: Allergy Therapeutics (AGY): Consistent first-half revenue growth
Hardman & Co Research: Diurnal (DNL): . and more to come (news flow)
Hardman & Co Research: Tissue Regenix (TRX): Restructured to satisfy product demand
Hardman & Co Research: genedrive plc (GDR): Western market progress but developing markets difficult
Hardman & Co Research: Allergy Therapeutics (AGY): Sales growth well above market average
Edison Investment Research Limited: Edison issues initiation on Silence Therapeutics (SLN)
DGAP-News: Ergomed plc: Lewis Cameron, ehemals Leiter der globalen klinischen Entwicklung bei Covance, zum Chief Operating Officer ernannt
Hardman & Co Research: Diurnal (DNL): Successful DITEST Phase I trial outcome
Hardman & Co Research: genedrive plc (GDR): Regulatory hurdle leaped: hearing loss assay
Hardman & Co Research: Diurnal (DNL): Approaching a number of near-term milestones
Hardman & Co Research: genedrive plc (GDR): Acceleration of news flow expected
1 Wall Street Analyst Thinks AT&T Stock Is Going to $20. Is It a Buy?
AT&T (NYSE: T) stock has struggled in recent years, but Barclays analyst Kannan Venkateshwar believes the company deserves a higher valuation, considering the recent subscriber gains for its
Amarin Plc (AMRN) Q1 2024 Earnings Call Transcript
Image source: The Motley Fool.
Amarin Plc (NASDAQ: AMRN)Q1 2024 Earnings CallMay 01, 2024, 8:00 a.m. ET
Operator
Source Fool.com
Better Dividend Stock: AT&T vs. Verizon
Income-seeking investors want to turn their heads toward the telecommunications industry. Two members of America's three-way telecom oligopoly offer huge dividend yields above 6% at the moment.
Veri
Should You Buy the 3 Highest-Paying Dividend Stocks in the S&P 500?
Buying stocks based on one aspect of a company is a mistake, but often, investors get fixated. Income-focused investors, for example, often give dividend yield too much sway in their investment
It's Time to Buy AT&T Stock Hand Over Fist
Telecom giant AT&T (NYSE: T) slightly missed expectations for revenue and earnings when it reported its first-quarter results on Wednesday, but those headline figures don't tell the whole story
AstraZeneca Plc (AZN) Q1 2024 Earnings Call Transcript
Image source: The Motley Fool.
AstraZeneca Plc (NASDAQ: AZN)Q1 2024 Earnings CallApr 25, 2024, 6:45 a.m. ET
Operator
Source Fool.com
Is AT&T a Buy Now?
Shares of AT&T (NYSE: T) recently slipped about half a percentage point in response to first-quarter results that the telecom giant announced before the market opened on April 24.
First-quarter
Why AT&T Stock Ticked Up Today
Shares of AT&T (NYSE: T) were moving higher today. Investors applauded its latest quarterly results as the telecom giant easily beat expectations on the top and bottom lines.
As a result, the
AT&T; (T) Q1 2024 Earnings Call Transcript
Image source: The Motley Fool.
AT&T (NYSE: T)Q1 2024 Earnings CallApr 24, 2024, 8:30 a.m. ET
Operator
Source Fool.com